Prosight Management, LP Care Dx, Inc. Transaction History
Prosight Management, LP
- $281 Million
- Q1 2025
A detailed history of Prosight Management, LP transactions in Care Dx, Inc. stock. As of the latest transaction made, Prosight Management, LP holds 136,593 shares of CDNA stock, worth $2.56 Million. This represents 0.86% of its overall portfolio holdings.
Number of Shares
136,593
Previous 80,000
70.74%
Holding current value
$2.56 Million
Previous $1.71 Million
41.59%
% of portfolio
0.86%
Previous 0.51%
Shares
2 transactions
Others Institutions Holding CDNA
# of Institutions
230Shares Held
56.9MCall Options Held
51.2KPut Options Held
46K-
Black Rock Inc. New York, NY5.29MShares$99.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.83MShares$90.7 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.67MShares$50 Million0.01% of portfolio
-
State Street Corp Boston, MA2.48MShares$46.6 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.35MShares$44 Million0.45% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...